Grannus Biosciences

Grannus BioSciences LTD
Registered Offices
℅ Dundas and Wilson
191 West George Street,
Glasgow G2 2LD,
Scotland, U.K

• Privately held biotechnology company incorporated January 2004 under the Companies Acts in Scotland Registration Number SC240992

• Clinical stage novel anti-inflammatory products

• Exclusive World Wide License from the University of Glasgow to issued and pending patents

• Managed by Pharmetix Corp. of California, U.S.A.

• Corporate Counsel, Dundas & Wilson, Glasgow

www.grannusbiosciences.com
or contact
ir@grannusbiosciences.com
for more information

Grannus 2004-2005

• Grannus BioSciences Limited Announces Appointment of EGeen as CRO

• Grannus BioSciences Ltd. Announces Agreement for Preclinical and Clinical Stage Molecules

• Grannus receives a SCIS award from Targeting Innovation

• Grannus to file IND/CTA for human clinical testing

• Grannus receives Business Growth Fund Award from Scottish Enterprise

• Grannus receives Notice of Allowance in Australia and China for its patent applications

• Grannus appoints Iain McInnes and Robin Stevenson, Royal Infirmary Scotland and Dr. Minnie McMillan, USC School of Medicine to the Scientific Advisory Board

Grannus Shortcuts
Actinic Keratosis
Psoriasis
COPD
Press
Contact Information

NEWS & PUBLICATIONS

Grannus BioSciences Limited Announces Appointment of EGeen as CRO
12-12-05 — Grannus BioSciences Ltd (GBL), a bio-pharmaceutical company developing novel products to control inflammatory and hyperproliferative disorders, announced today the appointment of EGeen AS, a subsidiary of EGeen International, as CRO for the Company’s clinical development activities. Under the terms of the agreement...
more...

Grannus BioSciences Ltd. Announces Agreement for Preclinical and Clinical Stage Molecules
10-19-05 — Grannus BioSciences Ltd, a privately held biotechnology company developing anti-inflammatory products, announced today two separate agreements with Strathclyde University the first involving a clinical stage compound for use in...
more...

research & enterprise : Grannus Biosciences
Formed in 2004 through a collaboration between the University and US-based Pharmetix Corporation which provided seed funding. Further funding was supplied by...
www.gla.ac.uk/R-E/pub/spinouts/grannus.html

research & enterprise : News - Grannus BioSciences Limited
The University of Glasgow has announced the creation of a new biotechnology company...
www.gla.ac.uk/R-E/pub/news/ newsarchive/bioscience-spinout.html

Scottish Equity Partners
New biotechnology company Grannus BioSciences was today officially launched by the University of Glasgow. Grannus BioSciences has been formed through a collaboration with Glasgow University and...
www.sep.co.uk/venturer/press_synergyuni.html

Scottish Equity Partners
The Synergy Fund, a University Challenge Fund managed by Scottish Equity Partners, has made a trio of new investments this year in spinouts developing promising technologies from...
www.sep.co.uk/venturer/feature_synergyfund.html

talentscotland.com: Bioscience Spinout with a Celtic connection
The University of Glasgow has announced the creation of a new biotechnology company, Grannus BioSciences Limited. The Company has been formed through collaboration between...
www.talentscotland.com/view_item.aspx?item_id=1483

Biotext: News
A syndicate of investors has partnered to supply seed funding for new biotechnology company, Grannus BioSciences, which has...
www.biotext.co.uk/cmn/viewdoc.jsp?cat=all& ct=nw&docid=BEP1_News_0000062216

Nexxus: View
Grannus Biosciences Ltd. Grannus Biosciences Ltd 191 West George Street Glasgow G2 2LD Glasgow. Tel: 0141 304 6029 Fax: 0141 304 6034. Category. ...
www.nexxusscotland.com/companies/view.html?id=153